# ETP Ventures

> ETP Ventures is a VC fund backing Health Care and Biotechnology. See 3 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Total investments: 3
- Last investment: Nov 2022
- Lead investor: 33%
- Last updated: Aug 2026

ETP Ventures is a VC fund focused on Health Care and Biotechnology. ETP Ventures

## Contacts

5 contacts available for ETP Ventures. Shizune tracks 1 team members at ETP Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/etp-ventures?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 100% |
| Biotechnology | 2 | 67% |
| Medical | 1 | 33% |
| Nutrition | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 33% |
| Angel | 1 | 33% |
| Series A | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 2 | 67% |
| Hong Kong | 1 | 33% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Dr. Liu Xiaoling | Senior Investment Manager | 1 | https://shizune.co/investors/profile/dr-liu-xiaoling |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| SEIMEI | SEIMEI is a nutrition and anti-aging biotechnology brand. | $4M | Seed | Nov 18, 2022 | https://seimeinutrition.com/ |
| Deep Longevity | Deep Longevity is a biotechnology company transforming longevity R&D through AI-discovered biomarkers of aging using clinical blood tests, transcriptomic, proteomic, epigenetic, microbiome, behavioral, wearable, imaging, and multiple other data types. |  | Series A | Jul 14, 2020 | https://deeplongevity.com/ |
| Dima Biotech | Dima Biotech is a tumor immunotherapy and monoclonal antibody developer, specializing in the development of recombinant monoclonal antibodies for tumor immune products and services. It has the unique RECmAb digital monoclonal antibody technology, which can be used to obtain a variety of genus and high quality. Monoclonal antibodies. |  | Angel | Sep 11, 2019 | https://www.dimabio.com/ |

3 of 3 investments shown.

## Co-investors
- [Blue Focus PR Consulting](https://shizune.co/investors/profile/blue-focus-pr-consulting) — VC Fund, 1 deal together
- [Bold Capital Partners](https://shizune.co/investors/profile/bold-capital) — VC Fund, 1 deal together
- [Emerging Technology Partners](https://shizune.co/investors/profile/emerging-technology-partners) — VC Fund, 1 deal together
- [Formic Ventures](https://shizune.co/investors/profile/formic-ventures) — VC Fund, 1 deal together
- [Guoqian Venture Capital](https://shizune.co/investors/profile/guoqian-venture-capital) — VC Fund, 1 deal together
- [Huatai Zijin Investment](https://shizune.co/investors/profile/huatai-zijin-investment) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Alibaba Entrepreneurs Fund](https://shizune.co/investors/profile/alibaba-entrepreneurs-fund) — VC Fund
- [Animoca Brands](https://shizune.co/investors/profile/animoca-brands-corporation) — VC Fund
- [Gobi Partners](https://shizune.co/investors/profile/gobi-partners) — VC Fund

## Featured in investor lists
- [Biotechnology Investors in Hong Kong](https://shizune.co/investors/biotechnology-investors-hong-kong)
- [Biotechnology VC Funds in Hong Kong](https://shizune.co/investors/biotechnology-vc-funds-hong-kong)
- [Biotech VC Funds in Hong Kong](https://shizune.co/investors/biotech-vc-funds-hong-kong)
- [Health Care VC Funds in Hong Kong](https://shizune.co/investors/health-care-vc-funds-hong-kong)

## FAQ

### What does ETP Ventures invest in?

ETP Ventures invests primarily in Health Care, Biotechnology and Medical startups, most often at Seed and Angel stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact ETP Ventures?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at ETP Ventures?

The team at ETP Ventures includes Dr. Liu Xiaoling (Senior Investment Manager). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co